Literature DB >> 24957364

Hypophosphatemic rickets: etiology, clinical features and treatment.

Vito Pavone1, Gianluca Testa, Salvatore Gioitta Iachino, Francesco Roberto Evola, Sergio Avondo, Giuseppe Sessa.   

Abstract

Hypophosphatemic rickets (HR) is a genetic disorder, which prevents sufficient reabsorption of phosphate in the proximal renal tubule, with increased phosphate excretion, resulting in rickets. The more common form of HR is an X-linked inherited trait, with a prevalence of 1/20,000. The defective gene is located on the X chromosome, but females may present with a wide variety of clinical manifestations. The less common form of HR is caused by autosomal-dominant transmission. Activating mutations of the fibroblast growth factor 23 (FGF-23) gene and inactivating mutations in the phosphate regulating gene (PHEX gene with homologies to endopeptidases on the X chromosome), involved in the regulation of FGF-23, have been identified and have been implicated in the pathogenesis of these disturbances. A review of etiopathogenesis and clinical, differential diagnostic and therapeutic aspects of HR, with a particular emphasis on bone impairment, is reported.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24957364     DOI: 10.1007/s00590-014-1496-y

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  42 in total

Review 1.  Rickets in childhood.

Authors:  Zulf Mughal
Journal:  Semin Musculoskelet Radiol       Date:  2002-09       Impact factor: 1.777

2.  Growth in X-linked hypophosphatemic rickets.

Authors:  Gema Ariceta; Craig B Langman
Journal:  Eur J Pediatr       Date:  2006-12-14       Impact factor: 3.183

3.  Early biochemical findings in familial hypophosphataemic, hyperphosphaturic rickets and response to treatment.

Authors:  M W Moncrieff
Journal:  Arch Dis Child       Date:  1982-01       Impact factor: 3.791

Review 4.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

5.  Principles and results of corrective lower limb osteotomies for patients with vitamin D-resistant hypophosphatemic rickets.

Authors:  M Rubinovitch; S E Said; F H Glorieux; R L Cruess; E Rogala
Journal:  Clin Orthop Relat Res       Date:  1988-12       Impact factor: 4.176

Review 6.  Renal phosphate loss in hereditary and acquired disorders of bone mineralization.

Authors:  Bernhard Bielesz; Klaus Klaushofer; Rainer Oberbauer
Journal:  Bone       Date:  2004-12       Impact factor: 4.398

7.  Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.

Authors:  L Beck; Y Soumounou; J Martel; G Krishnamurthy; C Gauthier; C G Goodyer; H S Tenenhouse
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

8.  Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.

Authors:  Outi Makitie; Sanna Toiviainen-Salo; Eino Marttinen; Ilkka Kaitila; Etienne Sochett; Ilkka Sipila
Journal:  Horm Res       Date:  2008-01-21

9.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

Authors:  Frank Rutsch; Nico Ruf; Sucheta Vaingankar; Mohammad R Toliat; Anita Suk; Wolfgang Höhne; Galen Schauer; Mandy Lehmann; Tony Roscioli; Dirk Schnabel; Jörg T Epplen; Alex Knisely; Andrea Superti-Furga; James McGill; Marco Filippone; Alan R Sinaiko; Hillary Vallance; Bernd Hinrichs; Wendy Smith; Merry Ferre; Robert Terkeltaub; Peter Nürnberg
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

10.  Osteotomy and intramedullary nailing for the correction of progressive deformity in vitamin D-resistant hypophosphataemic rickets.

Authors:  K S Eyres; J Brown; D L Douglas
Journal:  J R Coll Surg Edinb       Date:  1993-02
View more
  26 in total

1.  Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice.

Authors:  Kelsey A Carpenter; Ryan D Ross
Journal:  J Bone Miner Res       Date:  2019-12-10       Impact factor: 6.741

Review 2.  Congenital Conditions of Hypophosphatemia Expressed in Adults.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-05-14       Impact factor: 4.333

Review 3.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

4.  Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.

Authors:  Kelsey A Carpenter; Reid Davison; Shruti Shakthivel; Kyle D Anderson; Frank C Ko; Ryan D Ross
Journal:  Bone       Date:  2021-09-16       Impact factor: 4.398

Review 5.  Windswept Deformity a Disease or a Symptom? A Systematic Review on the Aetiologies and Hypotheses of Simultaneous Genu Valgum and Varum in Children.

Authors:  Niels J Jansen; Romy B M Dockx; Adhiambo M Witlox; Saartje Straetemans; Heleen M Staal
Journal:  Children (Basel)       Date:  2022-05-10

6.  Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.

Authors:  Nadine Meyerhoff; Dieter Haffner; Hagen Staude; Elke Wühl; Michaela Marx; Rolf Beetz; Uwe Querfeld; Martin Holder; Heiko Billing; Wolfgang Rabl; Carmen Schröder; Olaf Hiort; Jürgen H Brämswig; Annette Richter-Unruh; Dirk Schnabel; Miroslav Živičnjak
Journal:  Pediatr Nephrol       Date:  2017-10-20       Impact factor: 3.714

7.  Dentoalveolar Abscesses Not Associated with Caries or Trauma: A Diagnostic Hallmark of Hypophosphatemic Rickets Initially Misdiagnosed as Hypochondroplasia.

Authors:  Silvia Elena Yacarini Paredes; Raquel Assed Bezerra Segato; Leila Daher Moreira; Alcides Moreira; Kranya Victoria Díaz Serrano; Clarissa Teles Rodrigues; Luciana Yamamoto Almeida; Jorge Esquiche León
Journal:  Head Neck Pathol       Date:  2017-11-30

8.  Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.

Authors:  Eric T Rush; Britt Johnson; Swaroop Aradhya; Daniel Beltran; Sara L Bristow; Scott Eisenbeis; Norma E Guerra; Stan Krolczyk; Nicole Miller; Ana Morales; Prameela Ramesan; Soodabeh Sarafrazi; Rebecca Truty; Kathryn Dahir
Journal:  J Bone Miner Res       Date:  2021-11-10       Impact factor: 6.390

Review 9.  Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective.

Authors:  Yogesh Nv Reddy; Varun Sundaram; Georgi Abraham; Prethivee Nagarajan; Yuvaram Nv Reddy
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-23

10.  X-linked Hypophosphatemic Rickets, del(2)(q37.1;q37.3) Deletion Syndrome and Mosaic Turner Syndrome, mos 45,X/46,X, del(2)(q37.1;q37.3) in a 3-year-old Female.

Authors:  Alaina P Vidmar; Brian Miyazaki; Pedro A Sanchez-Lara; Pisit Pitukcheewanont
Journal:  J Bone Metab       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.